Insomnia treatment market to value over USD 5.8 Billion by 2029 end and register a CAGR of over 5.2% from 2019 to 2029.
Insomnia is a medical condition where the patient faces trouble sleeping. This disorder is highly prevalent and affects millions, characterised by symptoms like low stamina, daytime sleepiness, depression, and irritability.
Improvements in technology providing quick, new, advanced cures have readily been accepted and have received a favourable response thus leading to the growth of the market. The developing countries have vast untapped markets with huge potential, therefore, serving as new avenues for trade. All the market drivers outpower the restraints and thus the market is poised to grow at healthy CAGR. Growing awareness and availability of cures and diagnosis has boosted the growth of this market. The rising geriatric population creates excess demand as the elder generation is more susceptible to sleep disorders.
Minimal price and quick, effective and positive results are major drivers of this market globally. Various therapies and devices are available in the market and the various options assist the customer while providing lucrative trade opportunities for the market worldwide. Constant innovation helps improve therapies and cures. Improved devices such as Ebb Insomnia Therapy, Fisher Wallace Stimulator, and Alpha-Stim AID have already received approvals from FDA thus increasing the scope of the market. Moreover, products such as Sana Sleep are awaiting approval. With the introduction of new therapeutic devices, the market is expected to witness robust growth over the forecast period.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=258&page=requestsample
Global Insomnia Treatment Market Segmentation
By Drug Type
• OTC Drugs
• OTC Sleep Aids
• OTC Sleep Supplements
• Prescription Drugs
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce
• Drug Stores
• Others
By Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
North America is the largest shareholder globally and is projected to grow at a steady CAGR.
Growing prevalence of sleep disorders has raised the demand for diagnosis and treatment for the same and this is a driving factor for the market in this region. The markets in Europe and the region of Asia Pacific are also speculated to witness steady growth.
Purchase a Copy of this Premium Research Report & Ask for Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=258&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
The global market is characterised by several firms. Market influencers are focusing on the development of new molecules, in an attempt for anti-counterfeiting, to gain a competitive edge and tap the high unmet needs in the market. Firms holding major market share are Merck & Co., Mylan N.V., Paratek Pharmaceuticals, Inc., Pfizer Inc. and Sanofi S.A.
The booming multi-billion dollar sleep-health economy is an answer to the increasing number of insomnia cases, eventually opening an array of beneficial market opportunities for both private and consumer-oriented pharmaceutical companies, manufacturers, retailers, and health service providers.
FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data points affecting market growth
Objectives of the Study:
• To provide an exhaustive analysis on the global insomnia treatment market by drug type, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East.
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents
1. Market Introduction
• Market Definition
• Market Taxonomy
2. Executive Summary
• Market Overview
• Market Analysis
3. Market Dynamics
• Macro-Economic Factors
• Drivers
• Restraints
• Opportunity Analysis
• Trends
4. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Drug Type, 2014–2018
OTC Drugs
• OTC Sleep Aids
• OTC Sleep Supplements
Prescription Drugs
Market Size (US$ Mn) Forecast By Drug Type, 2019–2029
5. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2018
• Hospital Pharmacies
• Retail Pharmacies
• e commerce
• Drug Stores
• Others
6. North America Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029
• Introduction
• Regional Market Trends
• U.S.
• Canada
• Market Size (US$ Mn) Forecast By Country, 2019–2029
7. Latin America Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029
• Introduction
• Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Market Size (US$ Mn) Forecast By Country, 2019–2029
8. Europe Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029
• Introduction
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Market Size (US$ Mn) Forecast By Country, 2019–2029
9. Asia Pacific Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029
• Introduction
• Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
• China
• Japan
• India
• Australia and New Zealand
• ASEAN
• Rest of Asia Pacific
• Market Size (US$ Mn) Forecast By Country, 2019–2029
10. Middle East & Africa Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029
• Introduction
• Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
• GCC Countries
• South Africa
• Rest of MEA
• Market Size (US$ Mn) Forecast By Country, 2019–2029
11. Competition Analysis
• Merck & Co. Inc.
• Natrol, LLC
• GlaxoSmithKline Plc.
• Sanofi SA
• Pfizer Inc.
• Boehringer Ingelheim International GmbH
• Mallinckrodt
• PERNIX Therapeutics
• Takeda Pharmaceutical Company Limited
• Sunovion Pharmaceuticals, Inc.

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com